期刊文献+

HPLC同时测定复尔康注射液中3种活性成分的含量 被引量:2

Simultaneous Determination of Three Active Constituents in Fuerkang Injection by HPLC
原文传递
导出
摘要 目的建立同时测定复尔康注射液中甘草酸铵、蒿酮和维A酸含量的HPLC分析方法。方法色谱柱:Dikma KromasilC18(4.6mm×250mm,5μm)色谱柱;流动相:乙腈-0.1%磷酸溶液,梯度洗脱;分段变波长测定;柱温:30℃;流速:1.0mL·min-1。结果甘草酸铵、蒿酮和维A酸的线性范围分别为:0.249~1.992μg(r=0.9999),0.4409~3.5272μg(r=0.9999)、0.138~1.104μg(r=0.9999)。平均回收率分别为98.89%,99.17%,99.02%,RSD为0.67%,0.59%,0.74%。结论该方法简便、快速、准确、具有良好的重复性和回收率,可作为该制剂的质量控制标准。 OBJECTIVE To establish a HPLC method for the simultaneous determination of ammonium glycyrrhizinate, artemisia ketone and tretinoin in Fuerkang injection. METHODS The separation was carried out on a Dikma Kromasil C18 column (4.6 mm× 250 mm, 5 μm). The mobile phase was acetonitrile-0.1% phosphoric acid solution with gradient elution and changeable wavelength detection. The column temperature was 30 ℃. The flow rate was 1.0 mL.min^-1. RESULTS The calibration curves were linear in the ranges of 0.249-1.992μg (r= 0.999 9) for ammonium glycyrrhizinate, 0.440 9- 3.527 2 μg (r= 0.999 9) for artemisia ketone, 0.138-1.104 μg (r= 0.999 9) for tretinoin. The average recoveries were 98.89 % with RSD 0.67 % for ammonium glycyrrhizinate, 99.17% withRSD 0.59% for artemisia ketone, 99.02% with RSD 0.74% for tretinoin. CONCLUSION This method is simple, rapid, accurate and with good repeatability and recovery, it can be used as a quality control method for this preparation.
出处 《中国药学杂志》 CAS CSCD 北大核心 2009年第9期711-713,共3页 Chinese Pharmaceutical Journal
基金 四川省教育厅重点项目(082A114) 泸州市重点科技项目(泸市科函[2007]27号)
关键词 高效液相色谱法 复尔康注射液 甘草酸铵 蒿酮 维A酸 含量测定 HPLC Fuerkanginjection ammonium glycyrrhizinate artemisiaketone tretinoin content determination
  • 相关文献

参考文献6

二级参考文献13

  • 1陈发奎,郭允珍,孟宪纾.牛黄解毒片的三维高效液相色谱法鉴定和指标成分的定量[J].药学学报,1993,28(1):57-61. 被引量:8
  • 2彭洪,郭振德,张镜澄,刘莉玫.黄花蒿挥发油的成分研究[J].中药材,1996,19(9):458-459. 被引量:16
  • 3中国质谱学会有机专业委员会.香料质谱图集[M].北京,1992.146.
  • 4朱维华,药物分析杂志,1994年,14卷,4期,47页
  • 5周海钧,生物检定统计方法(第2版),1983年
  • 6国家药典委员会.中国药典:Ⅰ部[S].北京:化学工业出版社,2005.附录Ⅵ,ⅦA,ⅦG.
  • 7Chp(中国药典).2005.VolⅡ(二部):Appendix(附录)ⅦP
  • 8National Drug Standard(国家药品标准)WS-10001-(HD-0280)-2002
  • 9Masada Y.Analysis of essential oils by gas chromatography and mass spectrometry[M].New York:John wile and sons Inc.1976:32.
  • 10Heller SR,Milne GWA.EPA/NIH mass spectral data Base[M].Washington,US:Government Printing office,1980:46.

共引文献50

同被引文献10

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部